Scholars Central

Conference abstractPublished 7 Sep 2018

Novel Therapies in Pediatric Inflammatory Bowel Disease

Authors: Karen Frost

The Hospital for Sick Children, Canada

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The incidence and prevalence of Pediatric Inflammatory Bowel Disease (IBD) continue to rise. It is expected that earlier diagnosis lends to better treatment and outcome of disease. Nearly 1 in 4 patients are diagnosed at the age of under 20 years old . There are two main tiers of IBD: Crohn’s disease and Ulcerative Colitis. The exact cause is still unknown, however genetics and the environment do play a role. There is currently no cure for IBD, but patients are usually managed with treatment. Treatments can be approached in a step-up or top down algorithm. In the past, patients required steroids to achieve remission, or surgery was more imminent if lack of response was determined. At the present time, with more novel therapies in IBD, patients are able to achieve remission at a sooner time, thereby avoiding surgery. To date, there are therapies that include 5ASA, immunomodulators and biologic therapies. Biologic therapies are still seen as novel in pediatrics. The role of monoclonal antibodies (mAbs) play a huge role in the current IBD treatment paradigm. The focus of this topic will review pediatric armamentarium of mAbs such as Anti TNF, Anti ILs and gut selective mAbs, looking at it’s targeted mechanism, the dosing recommendation, safety data and current practice.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectGastroenterology & Hepatology
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Karen Frost”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels